FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
VIENNA, Austria — Global clinical results for the recently Food and Drug Administration (FDA) approved single-piece AcrySof SA30 (Alcon, Fort Worth, Texas) IOL are highly encouraging. “I think the ...
Evidence points to the decrease of posterior capsule opacification (PCO) in adults receiving the AcrySof (Alcon, Fort Worth, Texas) IOL, but pediatric surgeons are hoping to evaluate the same results ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results